Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8 + T cell response

Nature Immunology

Volumn 18, Issue 11, 2017, Pages 1228-1237

  Culshaw, Abigail ^a   Ladell, Kristin ^b   Gras, Stephanie ^c   McLaren, James E ^b   Miners, Kelly L ^b   Farenc, Carine ^c   Van Den Heuvel, Heleen ^c   Gostick, Emma ^b   Dejnirattisai, Wanwisa ^a   Wangteeraprasert, Apirath ^a,j   Duangchinda, Thaneeya ^d   Chotiyarnwong, Pojchong ^a,g,j   Limpitikul, Wannee ^e   Vasanawathana, Sirijitt ^f   Malasit, Prida ^g   Dong, Tao ^h   Rossjohn, Jamie ^b,c   Mongkolsapaya, Juthathip ^a,g   Price, David A ^b,i   Screaton, Gavin R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^e Songkhla Hospital   (Thailand)

^f KHON KAEN HOSPITAL   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j NARESUAN UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR; COMPLEMENTARITY DETERMINING REGION; HLA A ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NS3 PROTEASE, DENGUE VIRUS; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 2 BETA; CROSS REACTION; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; GENE LOCUS; HUMAN; IMMUNOREACTIVITY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEROTYPE; ADAPTIVE IMMUNITY; CHEMISTRY; CLASSIFICATION; DENGUE; GENETICS; GERMLINE MUTATION; IMMUNOLOGY; METABOLISM; MOLECULAR MODEL; PROTEIN TERTIARY STRUCTURE; SEROTYPING; SURFACE PLASMON RESONANCE; VIROLOGY;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; CROSS REACTIONS; DENGUE; DENGUE VIRUS; EPITOPES, T-LYMPHOCYTE; GERM-LINE MUTATION; HLA-A ANTIGENS; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SERINE ENDOPEPTIDASES; SEROTYPING; SURFACE PLASMON RESONANCE;

EID: 85031784242     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3850     Document Type: Article

References (56)

1. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
2. Sangkawibha, N. et al. Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120, 653-669 (1984).
3. Guzmán, M. G. et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152, 793-799, discussion 804 (2000).
4. Halstead, S. B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60, 421-467 (2003).
5. Morens, D. M., Larsen, L. K. & Halstead, S. B. Study of the distribution of antibodydependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies. J. Med. Virol. 22, 163-167 (1987).
6. Littaua, R., Kurane, I. & Ennis, F. A. Human IgG Fc receptor II mediates antibodydependent enhancement of dengue virus infection. J. Immunol. 144, 3183-3186 (1990).
7. Marchette, N. J., Halstead, S. B., Falkler, W. A. Jr., Stenhouse, A. & Nash, D. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J. Infect. Dis. 128, 23-30 (1973).
8. Halstead, S. B., Shotwell, H. & Casals, J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J. Infect. Dis. 128, 15-22 (1973).
9. Zellweger, R. M., Prestwood, T. R. & Shresta, S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7, 128-139 (2010).
10. Libraty, D. H. et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185, 1213-1221 (2002).
11. Simmons, C. P. et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 79, 5665-5675 (2005).
12. Duangchinda, T. et al. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl. Acad. Sci. USA 107, 16922-16927 (2010).
13. Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. USA 110, E2046-E2053 (2013).
14. Zellweger, R. M. et al. Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog. 9, e1003723 (2013).
15. Zellweger, R. M. et al. CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice. J. Virol. 89, 6494-6505 (2015).
16. Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372, 113-123 (2015).
17. Chandanayingyong, D. et al. HLA-A,-B,-DRB1,-DQA1, and-DQB1 polymorphism in Thais. Hum. Immunol. 53, 174-182 (1997).
18. Dung, N. T. et al. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J. Immunol. 184, 7281-7287 (2010).
19. Mongkolsapaya, J. et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9, 921-927 (2003).
20. Bridgeman, J. S., Sewell, A. K., Miles, J. J., Price, D. A. & Cole, D. K. Structural and biophysical determinants of T-cell antigen recognition. Immunology 135, 9-18 (2012).
21. Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169-200 (2015).
22. Beringer, D. X. et al. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Nat. Immunol. 16, 1153-1161 (2015).
23. Gras, S. et al. Reversed T cell receptor docking on a major histocompatibility class I complex limits involvement in the immune response. Immunity 45, 749-760 (2016).
24. Day, E. B. et al. Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses. Proc. Natl. Acad. Sci. USA 108, 9536-9541 (2011).
25. Gras, S. et al. Allelic polymorphism in the T cell receptor and its impact on immune responses. J. Exp. Med. 207, 1555-1567 (2010).
26. Miles, J. J. et al. CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol. 175, 3826-3834 (2005).
27. Adams, J. J. et al. Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity. Nat. Immunol. 17, 87-94 (2016).
28. Feng, D., Bond, C. J., Ely, L. K., Maynard, J. & Garcia, K. C. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8, 975-983 (2007).
29. Stadinski, B. D. et al. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. Immunity 35, 694-704 (2011).
30. Loke, H. et al. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword J. Infect. Dis. 184, 1369-1373 (2001).
31. Nguyen, T. P. et al. Protective and enhancing HLA alleles, HLA-DRB10901 and HLA-A24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl. Trop. Dis. 2, e304 (2008).
32. Appanna, R., Ponnampalavanar, S., Lum Chai See, L. & Sekaran, S. D. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One 5, e13029 (2010).
33. Malavige, G. N. et al. HLA class I and class II associations in dengue viral infections in a Sri Lankan population. PLoS One 6, e20581 (2011).
34. Stephens, H. A. et al. HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60, 309-318 (2002).
35. Vejbaesya, S. et al. HLA class I supertype associations with clinical outcome of secondary dengue virus infections in ethnic Thais. J. Infect. Dis. 212, 939-947 (2015).
36. Kouri, G. P., Guzmán, M. G., Bravo, J. R. & Triana, C. Dengue haemorrhagic fever/ dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull. World Health Organ. 67, 375-380 (1989).
37. Alvarez, M. et al. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 75, 1113-1117 (2006).
38. OhAinle, M. et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci. Transl. Med. 3, 114ra128 (2011).
39. Mongkolsapaya, J. et al. T cell responses in dengue hemorrhagic fever: Are crossreactive T cells suboptimal J. Immunol. 176, 3821-3829 (2006).
40. Chau, T. N. et al. Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 198, 516-524 (2008).
41. Friberg, H. et al. Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol. Cell Biol. 89, 122-129 (2011).
42. Yenchitsomanus, P. T. et al. Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR). Southeast Asian J. Trop. Med. Public Health 27, 228-236 (1996).
43. Innis, B. L. et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40, 418-427 (1989).
44. Jirakanjanakit, N., Sanohsomneing, T., Yoksan, S. & Bhamarapravati, N. The microfocus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue. Trans. R. Soc. Trop. Med. Hyg. 91, 614-617 (1997).
45. Dengue haemorrhagic fever: diagnosis, prevention, treatment and control. Geneva: World Health Organization; 1997.
46. Quigley, M. F., Almeida, J. R., Price, D. A. & Douek, D. C. Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR. in Current Protocols in Immunology. Ch. 10, Unit 10:33 (Wiley, 2011).
47. Lefranc, M. P. et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33, D593-D597 (2005).
48. Gras, S. et al. The shaping of T cell receptor recognition by self-tolerance. Immunity 30, 193-203 (2009).
49. Clements, C. S. et al. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr. D Biol. Crystallogr. 58, 2131-2134 (2002).
50. Reid, S. W. et al. Production and crystallization of MHC class I B allele single peptide complexes. FEBS Lett. 383, 119-123 (1996).
51. Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132 (2010).
52. Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72-82 (2006).
53. Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D Biol. Crystallogr. 57, 1373-1382 (2001).
54. Gras, S. et al. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J. Immunol. 183, 430-437 (2009).
55. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
56. Borg, N. A. et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat. Immunol. 6, 171-180 (2005).